Wells Fargo & Company Sana Biotechnology, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 47,398 shares of SANA stock, worth $239,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,398

Previous 34,904 35.8%

Holding current value

$239,359

Previous $349,000 26.07%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.23 - $10.44 $65,343 - $130,437	12,494 Added 35.8%	47,398 $258,000
Q1 2024 May 10, 2024	BUY	$4.2 - $11.27 $18,820 - $50,500	4,481 Added 14.73%	34,904 $349,000
Q4 2023 Feb 09, 2024	SELL	$2.8 - $4.55 $147,268 - $239,311	-52,596 Reduced 63.35%	30,423 $124,000
Q3 2023 Nov 13, 2023	SELL	$3.77 - $6.23 $35,860 - $59,259	-9,512 Reduced 10.28%	83,019 $321,000
Q2 2023 Aug 15, 2023	BUY	$3.22 - $7.53 $27,563 - $64,456	8,560 Added 10.19%	92,531 $551,000
Q1 2023 May 12, 2023	BUY	$3.11 - $4.92 $260,506 - $412,118	83,764 Added 40465.7%	83,971 $274,000
Q4 2022 Feb 13, 2023	SELL	$3.19 - $6.46 $9,464 - $19,166	-2,967 Reduced 93.48%	207 $0
Q3 2022 Nov 14, 2022	SELL	$5.58 - $9.04 $9,965 - $16,145	-1,786 Reduced 36.01%	3,174 $19,000
Q2 2022 Aug 12, 2022	SELL	$4.12 - $9.35 $12,508 - $28,386	-3,036 Reduced 37.97%	4,960 $32,000
Q1 2022 May 16, 2022	SELL	$5.24 - $15.58 $155,214 - $461,495	-29,621 Reduced 78.74%	7,996 $66,000
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $563,754 - $859,744	37,138 Added 7753.24%	37,617 $583,000
Q3 2021 Nov 15, 2021	SELL	$16.29 - $25.88 $3,762 - $5,978	-231 Reduced 32.54%	479 $11,000
Q2 2021 Aug 16, 2021	BUY	$16.65 - $32.14 $8,191 - $15,812	492 Added 225.69%	710 $14,000
Q1 2021 May 13, 2021	BUY	$23.04 - $43.5 $5,022 - $9,483	218 New	218 $7,000

Others Institutions Holding SANA

# of Institutions

163

Shares Held

121M

Call Options Held

811K

Put Options Held

1.02M

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $961M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Sana Biotechnology, Inc. Transaction History